"We're happy. Today is a red letter day in CBAI's history. We told our shareholders that acquisitions are one of the key ways to grow our Company. This acquisition would add a major stem cell collection company, with an excellent reputation and operations, to the Cord Blood America family of companies," said Matthew Schissler, co-founder, CEO and President. "We will keep our shareholders apprised of the progress of this acquisition as it moves forward. We will focus all of our efforts on bringing this to a successful close." http://finance.yahoo.com/news/Cord-Blood-America-Signs-prnews-1510255359.html?x=0&.v=1